LifeStance Health (LFST) Cost of Revenue (2020 - 2024)

LifeStance Health (LFST) has 5 years of Cost of Revenue data on file, last reported at $212.3 million in Q3 2024.

• Quarterly Cost of Revenue rose 13.72% year-over-year to $212.3 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $829.8 million (up 14.78% YoY) and the FY2023 annual result came in at $753.6 million, up 21.05% from the prior year.
• Cost of Revenue fell to $212.3 million in Q3 2024 per LFST's latest filing, from $214.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $214.5 million in Q2 2024 and bottomed at $31.3 million in Q2 2020.
• The 5-year median for Cost of Revenue is $157.3 million (2022), against an average of $151.5 million.
• The widest annual swing landed in 2021, when Cost of Revenue soared 249.61%; it then gained 12.42% in 2024.
• Tracing LFST's Cost of Revenue over 5 years: stood at $68.8 million in 2020, then surged by 97.17% to $135.7 million in 2021, then rose by 22.78% to $166.7 million in 2022, then gained by 18.37% to $197.3 million in 2023, then grew by 7.6% to $212.3 million in 2024.
• Per Business Quant, the three latest LFST Cost of Revenue figures stand at $212.3 million (Q3 2024), $214.5 million (Q2 2024), and $205.7 million (Q1 2024).

Peer Comparison